Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,075
Closed -$1.25M 4184
2025
Q4
$1.25M Buy
21,075
+16,937
+409% +$919K 0.03% 871
2025
Q3
$228K Buy
+4,138
New +$215K 0.01% 1740
2024
Q4
Sell
-6,665
Closed -$260K 2723
2024
Q3
$260K Buy
+6,665
New +$265K 0.02% 1282
2024
Q2
Sell
-4,377
Closed -$209K 2268
2024
Q1
$209K Buy
+4,377
New +$197K 0.03% 1139
2023
Q4
Sell
-6,613
Closed -$315K 1936
2023
Q3
$315K Buy
+6,613
New +$361K 0.05% 696
2023
Q2
Sell
-4,202
Closed -$301K 1684
2023
Q1
$301K Buy
+4,202
New +$334K 0.06% 645

Other funds holding NGVT

XTX Topco's NGVT Position: Q1 2026 in Review

XTX Topco sold out of Ingevity (NGVT) in Q1 2026, closing a stake of 21,075 shares — an estimated $1.25M sold.

XTX Topco first reported a position in NGVT in Q1 2023 and held it in 6 quarters. The position peaked at $1.25M in Q4 2025. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • XTX Topco reported no remaining Ingevity position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 21,075 Ingevity shares in Q1 2026, an estimated $1.25M.
  • XTX Topco first reported a position in Ingevity in Q1 2023 and held it in 6 quarters.
  • XTX Topco's Ingevity position peaked at $1.25M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.